These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11428516)
1. Modified immunoregulation associated with interferon-gamma treatment of rat glioma. Oshiro S; Liu Y; Fukushima T; Asotra K; Black KL Neurol Res; 2001 Jun; 23(4):359-66. PubMed ID: 11428516 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and modified immunoregulation associated with IFN-gamma treatment of RG2 gliomas. Oshiro S; Fukushima T; Tomonaga M; Black KL Anticancer Res; 1999; 19(6B):5029-36. PubMed ID: 10697506 [TBL] [Abstract][Full Text] [Related]
3. Response of MHC class-1 antigen on rat glioma cells to cytokines. Oshiro S; Fukushima T; Tomonaga M; Black KL Anticancer Res; 2000; 20(1C):605-10. PubMed ID: 10769703 [TBL] [Abstract][Full Text] [Related]
4. Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7. Nakano S; Matsukado K; Black KL Neurol Res; 1997 Oct; 19(5):501-8. PubMed ID: 9329027 [TBL] [Abstract][Full Text] [Related]
5. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. Akbasak A; Oldfield EH; Saris SC J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122 [TBL] [Abstract][Full Text] [Related]
6. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. Inamura T; Nomura T; Bartus RT; Black KL J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623 [TBL] [Abstract][Full Text] [Related]
7. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes. Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494 [TBL] [Abstract][Full Text] [Related]
8. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148 [TBL] [Abstract][Full Text] [Related]
9. Effects of gamma-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy. Wen PY; Lampson MA; Lampson LA J Neuroimmunol; 1992 Jan; 36(1):57-68. PubMed ID: 1735769 [TBL] [Abstract][Full Text] [Related]
10. Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma. Smith KE; Janelidze S; Visse E; Badn W; Salford L; Siesjö P; Darabi A Int J Cancer; 2007 Jan; 120(1):75-80. PubMed ID: 17044023 [TBL] [Abstract][Full Text] [Related]
11. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies. Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290 [TBL] [Abstract][Full Text] [Related]
12. Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts. Siesjö P; Visse E; Lindvall M; Salford L; Sjögren HO Cancer Immunol Immunother; 1993 Jul; 37(1):67-74. PubMed ID: 8513454 [TBL] [Abstract][Full Text] [Related]
13. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma. Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933 [TBL] [Abstract][Full Text] [Related]
14. Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Schartner JM; Hagar AR; Van Handel M; Zhang L; Nadkarni N; Badie B Glia; 2005 Sep; 51(4):279-85. PubMed ID: 15818597 [TBL] [Abstract][Full Text] [Related]
15. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs. Naganuma H; Sasaki A; Satoh E; Nagasaka M; Nakano S; Isoe S; Nukui H J Neurooncol; 1998 Sep; 39(3):227-36. PubMed ID: 9821108 [TBL] [Abstract][Full Text] [Related]
17. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. Black KL; Cloughesy T; Huang SC; Gobin YP; Zhou Y; Grous J; Nelson G; Farahani K; Hoh CK; Phelps M J Neurosurg; 1997 Apr; 86(4):603-9. PubMed ID: 9120622 [TBL] [Abstract][Full Text] [Related]
18. Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer. Arosarena OA; Baranwal S; Strome S; Wolf GT; Krauss JC; Bradford CR; Carey TE Otolaryngol Head Neck Surg; 1999 May; 120(5):665-71. PubMed ID: 10229590 [TBL] [Abstract][Full Text] [Related]
19. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155 [TBL] [Abstract][Full Text] [Related]